Pathfinder Focused Opportunities ETF
PFOE - ETF AI Analysis
Top Page
Pathfinder Focused Opportunities ETF (PFOE)
PFOE’s rating suggests it is a solid, but not risk‑free, ETF built around high‑quality growth companies. Strong contributors like TSM, ASML, and Alphabet support the fund with robust financial performance, positive earnings sentiment, and strategic positioning in advanced technologies and AI. However, holdings such as Spotify and QXO introduce risks related to overvaluation, bearish or overbought technical signals, and profitability or cash flow challenges, and the fund’s focus on tech and growth names means investors should be aware of sector and valuation risk.
PFOE vs. SPDR S&P 500 ETF (SPY)
- AUM
- 90.01M
- Region
- North America
- Expense Ratio
- 0.59%
- Beta
- 1.00
- Issuer
- Pathfinder
- Inception Date
- Dec 31, 2025
- Dividend Yield
- 0.27%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
PFOE Summary
Pathfinder Focused Opportunities ETF (PFOE) is an actively managed fund that looks for long-term growth by picking companies across the total stock market, rather than tracking a set index. It leans toward technology and communication services and holds well-known names like Alphabet (Google) and Netflix, along with other growth-focused businesses in the U.S. and abroad. Someone might invest in PFOE to seek higher growth and diversification across many sectors in a single fund. A key risk is that its growth-focused stocks and tech-heavy mix can be more volatile and can go up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, aiming to pick specific opportunities rather than just tracking a broad market index.
What would affect this ETF?
PFOE could benefit if technology, communication services, and health care companies like Alphabet, ASML, and UnitedHealth keep growing as digital services, streaming, and medical innovation expand, and if the U.S. economy remains healthy and supportive of growth-focused businesses. On the other hand, it could be hurt by rising interest rates that pressure growth stocks, tighter tech and health care regulations, or a downturn in the U.S. market that weighs on its concentrated holdings in a relatively small number of companies.
PFOE Top 10 Holdings
PFOE is leaning hard into innovative growth, with chip makers TSMC and ASML acting as key engines for the fund—TSMC has been steadily rising this year, while ASML’s longer-term strength is offset by some recent softness. Big health care names like Eli Lilly are another bright spot, climbing steadily and helping smooth out volatility. On the other side, Intuitive Surgical and Idexx have been lagging year-to-date, dulling some of that momentum. With a clear tilt toward technology and health care and mostly U.S. exposure plus a few global leaders, this ETF is betting on high-octane growth stories to drive returns.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 7.23% | $6.54M | $1.36T | 41.12% | 72Outperform | |
| TSMC | 6.67% | $6.03M | $1.85T | 41.29% | 81Outperform | |
| Spotify | 5.89% | $5.33M | $126.13B | -5.07% | 66Neutral | |
| Mercadolibre | 5.78% | $5.22M | $75.61B | -26.57% | 77Outperform | |
| ASML Holding | 5.76% | $5.21M | $563.74B | 46.60% | 81Outperform | |
| Alphabet Class C | 5.62% | $5.08M | $3.60T | 4.80% | 82Outperform | |
| Intuitive Surgical | 5.13% | $4.64M | $153.77B | -21.56% | 78Outperform | |
| Workday | 5.04% | $4.55M | $47.34B | -12.10% | 73Outperform | |
| UnitedHealth | 4.71% | $4.26M | $365.09B | 22.54% | 72Outperform | |
| QXO Inc | 4.56% | $4.13M | $13.07B | -27.96% | 66Neutral |
PFOE Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PFOE, the sentiment is Positive. The current price of 22.23 is above the 20-day moving average (MA) of 22.15, below the 50-day MA of 22.27, and below the 200-day MA of 23.00, indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 50.53 is Neutral, neither overbought nor oversold. The STOCH value of 65.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PFOE.
PFOE Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $22.23 | $25.00(12.48% Upside) | $90.01M | 0.59% | 74Outperform | |
| $34.37 | $38.03(10.64% Upside) | $98.92M | 0.87% | 71Outperform | |
| $37.80 | $42.79(13.19% Upside) | $93.99M | 0.85% | 69Neutral | |
| $31.98 | $36.47(14.05% Upside) | $89.68M | 0.75% | 70Outperform | |
| $35.70 | $42.58(19.24% Upside) | $86.06M | 0.65% | 62Neutral | |
| $72.36 | $81.26(12.30% Upside) | $75.83M | 0.52% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PFOE | Pathfinder Focused Opportunities ETF | 22.23 | -2.63 | -10.58% | |
| BAMD | Brookstone Dividend Stock ETF | 34.37 | 5.55 | 19.25% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 37.80 | 5.96 | 18.72% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.98 | 4.65 | 17.00% | |
| VAMO | Cambria Value & Momentum ETF | 35.70 | 3.87 | 12.16% | |
| RFDA | RiverFront Dynamic US Dividend Advantage ETF | 72.36 | 11.30 | 18.51% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
